John Collinge Selected Research

Infections

12/2019	Genetic Factors in Mammalian Prion Diseases.
1/2019	Enteral feeding is associated with longer survival in the advanced stages of prion disease.
11/2017	Soluble Aβ aggregates can inhibit prion propagation.
12/2016	Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine.
1/2016	Physical, chemical and kinetic factors affecting prion infectivity.
12/2015	Preclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion disease.
9/2015	Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.
8/2015	Identification of clinical target areas in the brainstem of prion-infected mice.
5/2015	Rare structural genetic variation in human prion diseases.
4/2014	Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Collinge Research Topics

Disease

126	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2023 - 01/2002
49	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2024 - 12/2002
47	Infections 12/2019 - 01/2003
34	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2023 - 12/2002
33	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 09/2009
26	Bovine Spongiform Encephalopathy (Mad Cow Disease) 12/2019 - 12/2002
23	Scrapie 12/2019 - 10/2002
17	Sporadic Creutzfeldt-Jakob Disease 11/2023 - 09/2006
12	Kuru 12/2019 - 06/2006
11	Disease Progression 01/2022 - 09/2006
11	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 12/2019 - 11/2006
10	Dementia (Dementias) 01/2024 - 02/2012
8	Frontotemporal Dementia (Semantic Dementia) 12/2019 - 02/2009
8	Acquired CJD 11/2017 - 12/2002
6	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2024 - 11/2013
4	Proteostasis Deficiencies 10/2022 - 05/2010
3	Chronic Wasting Disease 01/2022 - 10/2010
3	Brain Diseases (Brain Disorder) 11/2016 - 01/2016
3	Neuroblastoma 10/2014 - 02/2009
3	Genetic Predisposition to Disease (Genetic Predisposition) 11/2008 - 07/2004
2	Amyloid Plaque 11/2021 - 11/2013
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 10/2020
2	Tauopathies 12/2019 - 11/2013
2	Sarcoma (Soft Tissue Sarcoma) 03/2012 - 07/2010
2	Gliosis 03/2012 - 10/2010
2	Zoonoses 01/2012 - 11/2007
1	Myoclonus (Nocturnal Myoclonus) 01/2022
1	Movement Disorders (Movement Disorder) 01/2022
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 10/2020
1	Mixed Dementias 01/2020
1	Pick Disease of the Brain (Pick's Disease) 01/2020
1	Amyloid angiopathy 12/2018
1	Chromosome 3-Linked Frontotemporal Dementia 11/2017
1	Atrophy 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2015
1	Glioma (Gliomas) 06/2015
1	Autoimmune Diseases of the Nervous System 06/2015

Drug/Important Bio-Agent (IBA)

109	PrionsIBA 01/2024 - 10/2002
97	Prion ProteinsIBA 11/2023 - 01/2002
41	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2006
24	Amyloid (Amyloid Fibrils)IBA 01/2023 - 03/2006
21	Protein Isoforms (Isoforms)IBA 12/2016 - 01/2002
17	Codon (Codons)IBA 01/2022 - 12/2002
11	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2010
8	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 03/2006
7	Methionine (L-Methionine)FDA Link 01/2018 - 12/2002
6	AntibodiesIBA 01/2019 - 09/2004
6	UbiquitinIBA 03/2016 - 03/2008
5	Monoclonal AntibodiesIBA 01/2022 - 03/2003
5	ProgranulinsIBA 12/2018 - 03/2008
4	Growth Hormone (Somatotropin)IBA 01/2024 - 09/2015
4	Valine (L-Valine)FDA Link 01/2016 - 12/2007
3	Apolipoproteins E (ApoE)IBA 12/2019 - 09/2015
3	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2016 - 11/2005
3	DNA (Deoxyribonucleic Acid)IBA 03/2012 - 09/2009
3	DNA-Binding Proteins (DNA Binding Protein)IBA 03/2012 - 07/2010
3	Quinacrine (Mepacrine)IBA 01/2012 - 12/2006
2	Amyloid beta-PeptidesIBA 01/2024 - 05/2022
2	BenzodiazepinesIBA 01/2022 - 03/2014
2	tau Proteins (tau Protein)IBA 10/2020 - 12/2018
2	ApolipoproteinsIBA 12/2019 - 11/2017
2	LipidsIBA 09/2019 - 01/2019
2	Glutamate Receptors (Glutamate Receptor)IBA 07/2017 - 03/2014
2	Detergents (Detergent)IBA 01/2016 - 03/2009
2	Leucine (L-Leucine)FDA Link 06/2015 - 06/2006
2	Protein AggregatesIBA 10/2014 - 10/2010
2	EpitopesIBA 08/2013 - 11/2006
2	Antimalarials (Antimalarial Agents)IBA 01/2012 - 04/2009
2	Complement System Proteins (Complement)IBA 01/2011 - 07/2010
2	Endopeptidase K (Proteinase K)IBA 12/2010 - 12/2008
2	MetalsIBA 08/2010 - 12/2007
2	Messenger RNA (mRNA)IBA 05/2010 - 02/2009
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	mouse Prnp proteinIBA 01/2022
1	alpha-SynucleinIBA 01/2021
1	brazilinIBA 01/2021
1	Amyloidogenic ProteinsIBA 10/2020
1	SphingolipidsIBA 10/2020
1	SynucleinsIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Apolipoprotein E4IBA 12/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Antisense OligonucleotidesIBA 12/2018
1	Peptides (Polypeptides)IBA 12/2017
1	Glutamic Acid (Glutamate)FDA Link 07/2017
1	Reducing AgentsIBA 01/2016
1	Mitochondrial DNA (mtDNA)IBA 10/2015
1	PolymersIBA 07/2015
1	AntigensIBA 06/2015
1	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 06/2015
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2015
1	Glycine Receptors (Glycine Receptor)IBA 06/2015
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 06/2015
1	Stainless Steel (Steel, Stainless)IBA 04/2014
1	PowdersIBA 04/2014

Therapy/Procedure

16	Therapeutics 10/2022 - 03/2003
2	Operative Surgical Procedures 12/2018 - 03/2005
2	Blood Transfusion (Blood Transfusions) 02/2011 - 12/2006
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2020
1	Enteral Nutrition (Feeding, Tube) 01/2019